Dorgham, K.* ; Neumann, A.U. ; Decavele, M.* ; Luyt, C.E.* ; Yssel, H.* ; Gorochov, G.*
Considering personalized Interferon-β therapy for COVID-19.
Antimicrob. Agents Chemother. 65:e00065-21 (2021)
Softley, C. ; Zak, K.M.* ; Bostock, M.J. ; Fino, R. ; Zhou, R.X. ; Kolonko, M. ; Mejdi-Nitiu, R.* ; Meyer, H.* ; Sattler, M. ; Popowicz, G.M.
Structure and molecular recognition mechanism of IMP-13 metallo-β-lactamase.
Antimicrob. Agents Chemother. 64:e00123-20 (2020)
Softley, C. ; Zak, K.M. ; Bostock, M.J. ; Fino, R. ; Zhou, R.X. ; Kolonko, M. ; Mejdi-Nitiu, R.* ; Meyer, H.* ; Sattler, M. ; Popowicz, G.M.
Structure and molecular recognition mechanism of IMP-13 metallo-β-lactamase. (vol 64, e00123-20, 2020).
Antimicrob. Agents Chemother. 64:e01077-20 (2020)
Ko, C. ; Bester, R. ; Zhou, X.* ; Xu, Z.* ; Blossey, C. ; Sacherl, J. ; Vondran, F.W.R.* ; Gao, L.* ; Protzer, U.
A new role for capsid assembly modulators to target mature hepatitis B virus capsids and prevent virus infection.
Antimicrob. Agents Chemother. 64:e01440-19 (2019)
Cummings, J.E.* ; Kingry, L.C.* ; Rholl, D.A.* ; Schweizer, H.P.* ; Tonge, P.J.* ; Slayden, R.A.*
The Burkholderia pseudomallei enoyl-acyl carrier protein reductase FabI1 is essential for in vivo growth and is the target of a novel chemotherapeutic with efficacy.
Antimicrob. Agents Chemother. 58, 931-935 (2014)
Kremb, S. ; Helfer, M. ; Heller, W. ; Hoffmann, D.* ; Wolff, H. ; Kleinschmidt, A. ; Cepok, S.* ; Hemmer, B.* ; Durner, J. ; Brack-Werner, R.
EASY-HIT: HIV full-replication technology forbroad discovery of multiple classes of HIV inhibitors.
Antimicrob. Agents Chemother. 54, 5257-5268 (2010)
Jenke, A.C.* ; Wilhelm, A.D.* ; Orth, V.* ; Lipps, H.J.* ; Protzer, U. ; Wirth, S.*
Long-term suppression of hepatitis B virus replication by short hairpin RNA expression using the scaffold/matrix attachment region-based replicating vector system pEPI-1.
Antimicrob. Agents Chemother. 52, 2355-2359 (2008)